AIXN AiXin Life International, Inc.

OTC Retail-Drug Stores and Proprietary Stores CO CIK: 0000835662
AI RATING
STRONG_SELL
95% Confidence

Investment Thesis

AiXin Life International exhibits severe financial distress with negative stockholders' equity of -5.8M, indicating the company is technically insolvent. Massive operating losses (-1.8M), critically low liquidity (0.15x current ratio), and negative operating cash flow (-1.8M) demonstrate fundamental business viability concerns. The company's financial position deteriorated significantly despite revenue growth, suggesting poor cost management and operational performance.

Strengths

  • + Revenue grew 5091.7% year-over-year, indicating strong top-line demand or market expansion
  • + Gross profit positive at 1.4M suggests underlying product economics can be profitable at scale
  • + Some operating activity continues despite losses

Risks

  • ! Negative stockholders' equity of -5.8M indicates technical insolvency and high bankruptcy risk
  • ! Current ratio of 0.15x and quick ratio of 0.10x show critical liquidity crisis - liabilities exceed assets by 5.8M
  • ! Operating losses of -1.8M on 582.4K revenue demonstrate inability to control operating expenses despite revenue growth
  • ! Negative operating cash flow of -1.8M indicates cash burn and unsustainability of current operations
  • ! Minimal cash position of 19.1K cannot support ongoing losses or meet obligations
  • ! Liabilities of 9.2M far exceed assets of 3.4M, creating severe solvency risk

Key Metrics to Watch

Financial Metrics

Revenue
582.4K
Net Income
-1.4M
EPS (Diluted)
$-0.06
Free Cash Flow
-1.8M
Total Assets
3.4M
Cash
19.1K

Profitability Ratios

Gross Margin 238.7%
Operating Margin -316.0%
Net Margin -242.7%
ROE N/A
ROA -41.9%
FCF Margin -306.4%

Balance Sheet & Liquidity

Current Ratio
0.15x
Quick Ratio
0.10x
Debt/Equity
N/A
Debt/Assets
272.7%
Interest Coverage
-1,251.92x
Long-term Debt
N/A
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-03-19T17:47:50.874890 | Data as of: 2025-09-30 | Powered by Claude AI